CONMED Corporation

CNMD Healthcare Medical Devices

CONMED Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 5.18% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 11.6%, free cash flow grew 46.0% and total debt fell 5.40%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

46.72 0.42 −0.89%
Market cap
$1.4B
P/E
25.3×
Fwd P/E
8.8×
Dividend yield
0.00%
F-score
5/9
Altman Z
1.86
Beneish M
−2.70
Dividend safety
63/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

22.83 26.89 19.98 17.69
P/S ratio
1.08 0.92 0.79 0.72
P/FCF ratio
9.77 8.35 8.74 7.32
P/Operating CF
27.12 27.19 80.28 26.53
P/B ratio
1.44 1.22 1.06 0.95
EV/Sales
1.69 1.49 1.39 1.30
EV/EBITDA
11.50 11.25 9.91 9.33
EV/FCF
15.24 13.61 15.42 13.25
Current Ratio
2.10 2.14 2.29 1.48
Net Debt/EBITDA
25.65 13.93 18.14 14.10
Debt/Equity
0.85 0.81 0.85 0.80
Earnings Yield
4.38% 3.72% 5.01% 5.65%
Free Cash Flow Yield
10.23% 11.97% 11.44% 13.66%
Free Cash Flow per Share
1.57 1.33 0.35 1.14
Book value per Share
32.57 33.29 33.27 34.63
Free Cash Flow
48.50 41.22 10.58 34.16
EV/EBIT
19.16 20.02 17.02 16.14
Other line items

Show all line items

Columns are period end dates